Arm's $2B AGI CPU Demand Signals Data Center AI Shift

For AI infrastructure teams and model builders, Arm's move from licensing cores to selling its own AGI CPU shifts the data center compute stack. Orders above $2 billion and about 50% CPU compute share among top hyperscalers indicate that AI data centers are diversifying beyond GPU accelerators. But with the stock trading at 118x forward earnings, the key question is whether the AI compute upside has already been priced in.

Arm Holdings plc has become one of the market's clearest expressions of the AI-everything thesis. According to the 24/7 Wall St. model, Arm trades at 118x forward earnings after a 159.78% year-to-date rally, leaving the model's 12-month price target of $273.77 below the reference price of $287.64 and implying -4.82% downside. Monday's session cut 8.49% to near $283.97, leaving shares 36% below the 52-week high of $452.7. The central tension is that demand for Arm's first in-house chip, the AGI CPU, already exceeds $2 billion, and CEO Rene Haas says the initial market estimate 'may have been conservative,' yet the multiple is so elevated that the model rates Arm a hold rather than a buy.

“

model, Arm trades at 118x forward earnings after a 159.78% year-to-date rally, leaving the model's 12-month price target of $273.77 below the reference price of $287.64 and implying -4.82% downside.

The company's latest financial data show real growth but mixed profitability optics. First-quarter fiscal 2027 revenue rose 22.4% to $1.29 billion, beating the $1.27 billion estimate. Non-GAAP EPS of 45 cents rose 29%, but GAAP EPS of 25 cents missed expectations of 40 cents, pointing to substantial stock-based compensation or other adjustments. Management guided to $1.38 billion in revenue and $0.47 in non-GAAP EPS for the second quarter. Analysts expect EPS to climb from $2.2230 in fiscal 2027 to $3.0548 in fiscal 2028, a trajectory that supports the bull case, but the current share price already incorporates much of that earnings acceleration.

For the AI and data center market, the most important signal is Arm's shift from licensing cores to selling silicon. The AGI CPU, Arm's first in-house chip, has booked more than $2 billion in demand, and Haas indicated the addressable market may be larger than initial estimates. Arm Neoverse shipments have surpassed 1.5 billion cores, with 500 million shipped in just nine months, indicating that Arm-based infrastructure is scaling rapidly. The company claims about 50% of CPU compute share among top hyperscalers, with each major cloud provider rolling out its own Arm-based processor. Data center is expected to soon become Arm's largest business, overtaking its traditional licensing and royalty base.

The risk side is equally concrete. Wall Street's bear case for Arm falls to $219, driven by a pending Qualcomm trial scheduled for Q4 2026 and China export controls that affect roughly $200 million in revenue. Qualcomm is a major Arm licensee, so the outcome of that litigation could affect royalty rates and licensing architecture across the mobile and edge ecosystem. The China restrictions create direct revenue exposure at a time when geopolitical controls on advanced semiconductors are tightening. These factors explain why the model's price target sits below current trading levels despite consensus EPS growth.